Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Seminars in Hematology|March 31, 2010
Rituximab in chronic lymphocytic leukemiaSamantha M Jaglowski, John C ByrdBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemiaSamantha M Jaglowski, John C ByrdCurrent Opinion in Hematology|January 29, 2014
Graft-versus-host disease: why have we not made more progress?Samantha M Jaglowski, Steven M DevineBlood Advances|August 16, 2018
How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHDSamantha M Jaglowski, Bruce R BlazarAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 9, 2016
Ibrutinib for treatment of chronic lymphocytic leukemiaCory M Vela, Ali McBride, Samantha M Jaglowski, et al.Seminars in Oncology|October 20, 2009
Lymphoma in adolescents and young adultsSamantha M Jaglowski, Erica Linden, Amanda M Termuhlen, et al.Blood|July 9, 2010
The clinical application of monoclonal antibodies in chronic lymphocytic leukemiaSamantha M Jaglowski, Lapo Alinari, Rosa Lapalombella, et al.Journal of the American Academy of Dermatology|July 22, 2021
Cutaneous manifestations of chimeric antigen receptor T-cell therapy: An introduction for dermatologistsKelsey B Nusbaum, Brittany Dulmage, Jennifer N Choi, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2020
A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703Zachariah DeFilipp, Linda J Burns, Samantha M Jaglowski, et al.Cancer Management and Research|December 8, 2021
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution ExperienceAndrew Schaefer, Ying Huang, Adam Kittai, et al.Pageof 4